CN1281763C - Process for detecting Enterobacter sakazakii by employing fluorescence PCR technology - Google Patents
Process for detecting Enterobacter sakazakii by employing fluorescence PCR technology Download PDFInfo
- Publication number
- CN1281763C CN1281763C CNB2004100728528A CN200410072852A CN1281763C CN 1281763 C CN1281763 C CN 1281763C CN B2004100728528 A CNB2004100728528 A CN B2004100728528A CN 200410072852 A CN200410072852 A CN 200410072852A CN 1281763 C CN1281763 C CN 1281763C
- Authority
- CN
- China
- Prior art keywords
- fluorescent
- enterobacter sakazakii
- pcr
- chimeric
- sample
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 241001135265 Cronobacter sakazakii Species 0.000 title claims abstract description 67
- 238000000034 method Methods 0.000 title claims abstract description 64
- 238000005516 engineering process Methods 0.000 title claims abstract description 13
- 239000013612 plasmid Substances 0.000 claims abstract description 46
- 238000001514 detection method Methods 0.000 claims abstract description 21
- 239000007850 fluorescent dye Substances 0.000 claims abstract description 21
- 230000003321 amplification Effects 0.000 claims abstract description 13
- 238000003199 nucleic acid amplification method Methods 0.000 claims abstract description 11
- 238000002844 melting Methods 0.000 claims description 25
- 230000008018 melting Effects 0.000 claims description 25
- 239000000203 mixture Substances 0.000 claims description 14
- 239000012634 fragment Substances 0.000 claims description 13
- 239000012154 double-distilled water Substances 0.000 claims description 7
- 239000000470 constituent Substances 0.000 claims 1
- 239000000523 sample Substances 0.000 abstract description 127
- 108090000623 proteins and genes Proteins 0.000 abstract description 7
- 108091034117 Oligonucleotide Proteins 0.000 abstract description 5
- 230000001580 bacterial effect Effects 0.000 abstract description 4
- 230000035945 sensitivity Effects 0.000 abstract description 4
- 239000003155 DNA primer Substances 0.000 abstract description 3
- 238000013461 design Methods 0.000 abstract description 3
- 239000002751 oligonucleotide probe Substances 0.000 abstract description 2
- 238000004445 quantitative analysis Methods 0.000 abstract description 2
- 238000010561 standard procedure Methods 0.000 abstract description 2
- 108090000790 Enzymes Proteins 0.000 abstract 1
- 102000004190 Enzymes Human genes 0.000 abstract 1
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- 239000013615 primer Substances 0.000 description 31
- 239000000843 powder Substances 0.000 description 21
- 239000008267 milk Substances 0.000 description 18
- 210000004080 milk Anatomy 0.000 description 18
- 235000013336 milk Nutrition 0.000 description 18
- 108060002716 Exonuclease Proteins 0.000 description 17
- 102000013165 exonuclease Human genes 0.000 description 17
- 241000894006 Bacteria Species 0.000 description 11
- 239000006228 supernatant Substances 0.000 description 10
- 238000012360 testing method Methods 0.000 description 10
- 238000002474 experimental method Methods 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 239000013642 negative control Substances 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 239000013641 positive control Substances 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 235000013350 formula milk Nutrition 0.000 description 5
- 238000007689 inspection Methods 0.000 description 5
- 241000588697 Enterobacter cloacae Species 0.000 description 4
- 241000588724 Escherichia coli Species 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 241000588919 Citrobacter freundii Species 0.000 description 3
- 238000007400 DNA extraction Methods 0.000 description 3
- 241000588915 Klebsiella aerogenes Species 0.000 description 3
- 238000012408 PCR amplification Methods 0.000 description 3
- 244000052616 bacterial pathogen Species 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 229940092559 enterobacter aerogenes Drugs 0.000 description 3
- 238000001802 infusion Methods 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 230000004544 DNA amplification Effects 0.000 description 2
- 241000588921 Enterobacteriaceae Species 0.000 description 2
- 241000588731 Hafnia Species 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 102000016943 Muramidase Human genes 0.000 description 2
- 108010014251 Muramidase Proteins 0.000 description 2
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- 239000007984 Tris EDTA buffer Substances 0.000 description 2
- 108010059993 Vancomycin Proteins 0.000 description 2
- 230000000692 anti-sense effect Effects 0.000 description 2
- 238000002306 biochemical method Methods 0.000 description 2
- 238000010876 biochemical test Methods 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- CJNBYAVZURUTKZ-UHFFFAOYSA-N hafnium(IV) oxide Inorganic materials O=[Hf]=O CJNBYAVZURUTKZ-UHFFFAOYSA-N 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 239000004325 lysozyme Substances 0.000 description 2
- 229960000274 lysozyme Drugs 0.000 description 2
- 235000010335 lysozyme Nutrition 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 238000009629 microbiological culture Methods 0.000 description 2
- 150000002989 phenols Chemical class 0.000 description 2
- 239000001632 sodium acetate Substances 0.000 description 2
- 235000017281 sodium acetate Nutrition 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 239000008223 sterile water Substances 0.000 description 2
- 239000012137 tryptone Substances 0.000 description 2
- MYPYJXKWCTUITO-LYRMYLQWSA-N vancomycin Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)NC)[C@H]1C[C@](C)(N)[C@H](O)[C@H](C)O1 MYPYJXKWCTUITO-LYRMYLQWSA-N 0.000 description 2
- 229960003165 vancomycin Drugs 0.000 description 2
- MYPYJXKWCTUITO-UHFFFAOYSA-N vancomycin Natural products O1C(C(=C2)Cl)=CC=C2C(O)C(C(NC(C2=CC(O)=CC(O)=C2C=2C(O)=CC=C3C=2)C(O)=O)=O)NC(=O)C3NC(=O)C2NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CC(C)C)NC)C(O)C(C=C3Cl)=CC=C3OC3=CC2=CC1=C3OC1OC(CO)C(O)C(O)C1OC1CC(C)(N)C(O)C(C)O1 MYPYJXKWCTUITO-UHFFFAOYSA-N 0.000 description 2
- 201000009906 Meningitis Diseases 0.000 description 1
- 206010051606 Necrotising colitis Diseases 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000004995 necrotizing enterocolitis Diseases 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 201000006195 perinatal necrotizing enterocolitis Diseases 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000002987 primer (paints) Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 239000001052 yellow pigment Substances 0.000 description 1
Images
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
技术领域technical field
本发明涉及细菌检验技术,具体地说是运用荧光PCR反应来检测致病细菌,特别是坂崎肠杆菌。The invention relates to a bacterium inspection technology, in particular to using fluorescent PCR reaction to detect pathogenic bacteria, especially Enterobacter sakazakii.
背景技术Background technique
坂崎肠杆菌(Enterobacter sakazakii)是革兰氏阴性细菌,属肠杆菌科肠杆菌属。1980年被命名为坂崎肠杆菌前,该菌被称为产黄色素阴沟肠杆菌。它是临床上很少见的病原菌,其引起的脑膜炎、败血症、坏死性小肠结肠炎在全世界范围内均有报告,并有不断增多的趋势,大多数病例发生在婴幼儿,而且病程短,有时病死率可达80%。虽然坂崎肠杆菌的传染源不很清楚,但婴儿配方奶粉起到了传播媒介的作用。2002年11月26日国家质检总局发布2002年第120号公告,其主要内容是暂停办理美国惠氏公司生产的某些批号的配方奶粉的报检通关和相关的检验检疫手续,对已进口的相关产品进行监督销毁处理,原因是美国食品与药品管理局(FDA)在上述产品中检出坂崎肠杆菌;2003年3月6日美赞臣公司也因发现一系列奶粉中含有坂崎肠杆菌,主动收回某些生产批号的婴幼儿奶粉。Enterobacter sakazakii is a Gram-negative bacterium belonging to the genus Enterobacteriaceae. Before being named Enterobacter sakazakii in 1980, the bacterium was known as Enterobacter cloacae producing yellow pigment. It is a clinically rare pathogen. The meningitis, sepsis, and necrotizing enterocolitis caused by it have been reported all over the world, and there is an increasing trend. Most of the cases occur in infants and young children, and the course of the disease is short. , and sometimes the fatality rate can reach 80%. Although the source of E. sakazakii infection is unclear, infant formula acts as a vector. On November 26, 2002, the General Administration of Quality Supervision, Inspection and Quarantine issued Announcement No. 120 of 2002, the main content of which was to suspend the customs clearance and related inspection and quarantine procedures for certain batches of formula milk powder produced by Wyeth Company of the United States. The relevant products were destroyed under supervision because the US Food and Drug Administration (FDA) detected Enterobacter sakazakii in the above products; on March 6, 2003, Mead Johnson Company also voluntarily recalled a series of milk powder containing Enterobacter sakazakii Certain batches of infant milk powder.
目前我国尚没有食品中和临床上检测坂崎肠杆菌的标准方法,美国FDA在2002年8月发布的坂崎肠杆菌分离计数方法,依然沿用了“三管”增菌法检测坂崎肠杆菌。其不足之处是需要经过前增菌、分离培养、生化鉴定等经典的检验方法检测目标菌,不仅试验时间长,而且灵敏度和特异性都相对较低。At present, there is no standard method for the detection of Enterobacter sakazakii in food and clinically in my country. The method for the isolation and counting of Enterobacter sakazakii released by the US FDA in August 2002 still uses the "three-tube" enrichment method to detect Enterobacter sakazakii. Its disadvantage is that it needs to detect the target bacteria through classic inspection methods such as pre-enrichment, isolation and culture, and biochemical identification. Not only does the test take a long time, but also the sensitivity and specificity are relatively low.
发明内容Contents of the invention
针对上述情况,本发明克服了现有技术中的缺点,提供一种运用荧光PCR技术检测坂崎肠杆菌的方法,具体地讲,通过检测外切酶探针PCR反应或荧光染料嵌合PCR反应中所发出的荧光信号,判断样品中是否含有坂崎肠杆菌。In view of the above situation, the present invention overcomes the shortcomings in the prior art and provides a method for detecting Enterobacter sakazakii using fluorescent PCR technology, specifically, by detecting exonuclease probe PCR reaction or fluorescent dye chimeric PCR reaction The emitted fluorescent signal can be used to determine whether the sample contains Enterobacter sakazakii.
本发明的技术方案如下:Technical scheme of the present invention is as follows:
1、通过外切酶探针PCR反应(Taqman探针法,以下简称探针法)检测坂崎肠杆菌,其使用的引物、探针及报告质粒扩增片段的序列如下:1. Detection of Enterobacter sakazakii by exonuclease probe PCR reaction (Taqman probe method, hereinafter referred to as probe method), the sequences of primers, probes and reporter plasmid amplified fragments used in it are as follows:
引物:Primers:
探针法引物序列1:CCGGAACAAGCTGAAAATTCTProbe primer sequence 1: CCGGAACAAGCTGAAAATTCT
探针法引物序列2:GTCTTCGTGCTGCGATTACProbe primer sequence 2: GTCTTCGTGCTGCGATTAC
探针:Probe:
探针法探针序列1:ACTCTGACACCGCGCATTCCTGProbe Method Probe Sequence 1: ACTCTGACACCGCGCATTCCTG
探针法探针序列2:CCTTTGGCGTTTCCCGATGTCCGTProbe Method Probe Sequence 2: CCTTTGGCGTTTCCCGATGTCCGT
探针法报告质粒的扩增片段:GGAGGGATTGCAGCGTGTTTTTAATGAGGTCATCACGGGATCCCATGTGCGTGACGGACATCGGGAAACGCCAAAGGAGATTAmplified fragment of probe method reporter plasmid: GGAGGGATTGCAGCGTGTTTTTAATGAGGTCATCACGGGATCCCATGTGCGTGACGGACATCGGGAAACGCCAAAGGAGATT
还包括由上述五条寡核苷酸序列衍生出来的、差别不大于8个碱基的寡核苷酸序列以及每个序列的反义互补序列,或它们的变体,或它们的部分序列。It also includes oligonucleotide sequences derived from the above five oligonucleotide sequences with a difference of not more than 8 bases, and the antisense complementary sequences of each sequence, or their variants, or their partial sequences.
PCR反应体系的组分:Components of the PCR reaction system:
成分 浓度 加样量Composition Concentration Concentration Sample Amount
PCR体系预混合物 2倍 12.5μL
探针法引物序列1 10μmol/L 0.5μLProbe
探针法引物序列2 10μmol/L 0.5μLProbe
探针法探针序列1 3μmol/L 1μLProbe
探针法探针序列2 3μmol/L 1μLProbe
DNA样品 1μLDNA sample 1μL
报告质粒 103个/μL 1μL
双蒸水 7.5μLDouble distilled water 7.5μL
总体积 25μLTotal volume 25μL
PCR扩增程序:PCR amplification program:
(1)95℃ 10秒(1) 95°C for 10 seconds
(2)95℃ 5秒(2) 95°C for 5 seconds
(3)62℃ 20秒(3) 62°C for 20 seconds
(4)回到第(2)步,重复45次。(4) Go back to step (2) and repeat 45 times.
检测过程:Detection process:
(1)设计特异性寡核苷酸引物、探针,将探针法的探针序列1用FAM荧光基团标记,将探针法的探针序列2用HEX荧光基团标记,用于外切酶探针荧光PCR检测;(1) Design specific oligonucleotide primers and probes, label the
(2)构建可以使用探针法引物序列1和探针法引物序列2扩增,且其扩增产物能和探针法探针序列2杂交的报告质粒,作为阳性对照质粒,防止出现假阴性结果。(2) Construction can use probe
(3)以探针法引物序列1和探针法引物序列2作为引物,以坂崎肠杆菌基因组DNA为模板,进行目的基因的特异性扩增;(3) using the probe
(4)扩增过程中使用荧光PCR仪进行实时荧光光强度测量,并将数据传输至电脑通过配套软件进行分析,可以观察到对坂崎肠杆菌进行特异性扩增产生的特定波长的FAM荧光信号,证明待测样品中存在坂崎肠杆菌;如仅观察到另一波长的HEX荧光信号而没有FAM荧光信号,则证明待测样品中不存在坂崎肠杆菌;如没有观察到任何一种荧光信号则表明此次检验失败,不能确定是否存在坂崎肠杆菌,需重新检验。(4) During the amplification process, a fluorescent PCR instrument is used for real-time fluorescence light intensity measurement, and the data is transmitted to the computer for analysis through supporting software. The FAM fluorescence signal of a specific wavelength generated by the specific amplification of Enterobacter sakazakii can be observed , proves that Enterobacter sakazakii exists in the sample to be tested; if only HEX fluorescence signal of another wavelength is observed but no FAM fluorescence signal, it proves that Enterobacter sakazakii does not exist in the sample to be tested; if no fluorescent signal is observed, then It indicates that the test failed, and the presence or absence of Enterobacter sakazakii cannot be determined, and a new test is required.
本发明用坂崎肠杆菌基因的特异性引物,通过外切酶探针PCR反应,可观察到特异性荧光信号,在已试验的30种不同属或同属的其它致病细菌中均未发现假阳性结果。The present invention uses the specific primers of the Enterobacter sakazakii gene, through exonuclease probe PCR reaction, can observe the specific fluorescent signal, and no false positive is found in the 30 kinds of other pathogenic bacteria of different genus or the same genus that have been tested result.
2、通过荧光染料嵌合PCR反应检测坂崎肠杆菌的方法(简称荧光嵌合法),其使用的引物序列和报告质粒扩增片段的序列如下:2. The method for detecting Enterobacter sakazakii by fluorescent dye chimeric PCR reaction (referred to as fluorescent chimeric method), the sequence of the primers used and the sequence of the reporter plasmid amplified fragment are as follows:
荧光嵌合法引物序列1:GGGTTGTCTGCGAATCGCTTFluorescent chimeric primer sequence 1: GGGTTGTCTGCGAATCGCTT
荧光嵌合法引物序列2:GTCTTCGTGCTGCGTCAAACFluorescent chimeric primer sequence 2: GTCTTCGTGCTGCGTCAAAC
荧光嵌合法报告质粒的扩增片段:TCCGTTCTTCTTCGTCATAACTTAATGTTTTTATTTAAAATACCCTCTGAAAAGAAAGGAAmplified fragment of fluorescent chimeric reporter plasmid: TCCGTTTCTTCTTCGTCATAACTTAATGTTTTTATTTAAAATACCCTCTGAAAAGAAAGGA
还包括由上述三条寡核苷酸序列衍生出来的、差别不大于8个碱基的寡核苷酸序列以及每个序列的反义互补序列,或它们的变体,或它们的部分序列。It also includes oligonucleotide sequences derived from the above three oligonucleotide sequences with a difference of not more than 8 bases, and the antisense complementary sequences of each sequence, or their variants, or their partial sequences.
PCR反应体系的组分:Components of the PCR reaction system:
成分 浓度 加样量Composition Concentration Concentration Sample Amount
PCR体系预混合物 2倍 12.5μL
荧光嵌合法所用引物序列1: 10μmol/L 0.5μL
荧光嵌合法所用引物序列2: 10μmol/L 0.5μL
DNA样品 1μLDNA sample 1μL
报告质粒 103个/μL 1μL
双蒸水 9.5μLDouble distilled water 9.5μL
总体积 25μLTotal volume 25μL
PCR扩增程序:PCR amplification program:
(1)95℃ 10秒(1) 95°C for 10 seconds
(2)95℃ 5秒(2) 95°C for 5 seconds
(3)58℃至65℃间的某一温度20秒(3) A certain temperature between 58°C and 65°C for 20 seconds
(4)回到第(2)步,重复45次。(4) Go back to step (2) and repeat 45 times.
(5)95℃2分(5) 95°C for 2 minutes
(6)梯度升温55℃至95℃,每25秒上升1℃。(6) Gradient temperature increase from 55°C to 95°C, increasing by 1°C every 25 seconds.
检测过程:Detection process:
(1)设计特异性寡核苷酸引物用于荧光染料嵌合荧光PCR检测;(1) Design specific oligonucleotide primers for fluorescent dye chimeric fluorescent PCR detection;
(2)构建可以使用荧光嵌合法引物序列1和荧光嵌合法引物序列2扩增的报告质粒,作为阳性对照质粒,防止出现假阴性结果。(2) Construct a reporter plasmid that can be amplified using the fluorescent chiseled
(3)以荧光嵌合法引物序列1和荧光嵌合法引物序列2作为引物,以坂崎肠杆菌基因组DNA为模板,进行目的基因的特异性扩增;(3) using the fluorescent
(4)扩增过程中使用荧光PCR仪进行实时荧光光强度测量,并在PCR反应结束后测定所合成DNA片段的熔解温度。将数据传输至电脑通过配套软件进行分析,可以观察到对坂崎肠杆菌进行特异性扩增产生的荧光,并得到对坂崎肠杆菌进行扩增产生的特异性片段所特有的熔解曲线(主峰87.1℃±0.5℃;次峰85.0±0.5℃),则证明待测样品中存在坂崎肠杆菌;如仅观察到荧光信号,而熔解曲线不符合坂崎肠杆菌特有的熔解曲线,且可以观察到报告质粒的荧光信号和扩增报告质粒的特异片段所产生的特有熔解曲线(峰值79.0±0.5℃),则证明待测样品中不存在坂崎肠杆菌;如出现其他结果则表明此次检验失败,不能确定是否存在坂崎肠杆菌,需重新检验。(4) During the amplification process, a fluorescent PCR instrument is used for real-time fluorescence light intensity measurement, and the melting temperature of the synthesized DNA fragment is measured after the PCR reaction is completed. Transfer the data to the computer and analyze it through supporting software. The fluorescence generated by the specific amplification of Enterobacter sakazakii can be observed, and the melting curve unique to the specific fragment generated by the amplification of Enterobacter sakazakii can be obtained (main peak 87.1°C ±0.5°C; secondary peak 85.0±0.5°C), it proves that there is Enterobacter sakazakii in the sample to be tested; if only the fluorescent signal is observed, but the melting curve does not conform to the specific melting curve of Enterobacter sakazakii, and the reporter plasmid can be observed The fluorescent signal and the unique melting curve (peak value 79.0±0.5°C) produced by the specific fragment of the amplified reporter plasmid prove that Enterobacter sakazakii does not exist in the sample to be tested; other results indicate that the test failed, and it cannot be determined whether The presence of Enterobacter sakazakii requires retesting.
本发明用坂崎肠杆菌基因的特异性引物通过荧光嵌合PCR报告荧光信号检测坂崎肠杆菌,在已试验的30种不同属或同属的其它致病细菌中均未发现假阳性结果。The invention uses the specific primers of the Enterobacter sakazakii gene to detect the Enterobacter sakazakii through the fluorescent chimeric PCR reporter fluorescent signal, and no false positive results are found in the 30 tested different genus or other pathogenic bacteria of the same genus.
3、待测样品中的坂崎肠杆菌培养方法:3. Culture method of Enterobacter sakazakii in the sample to be tested:
(1)配置专用培养基:胰蛋白胨20g,乳糖5g,K2HPO4 2.75g,KH2PO4 2.75g,NaCl 34.22g,月桂基硫酸钠0.1g,万古霉素10mg,加入无菌水至1升,调pH值至6.8±0.2;(1) Configure special medium: tryptone 20g, lactose 5g, K 2 HPO 4 2.75g, KH 2 PO 4 2.75g, NaCl 34.22g, sodium lauryl sulfate 0.1g, vancomycin 10mg, add sterile water to 1 liter, adjust the pH value to 6.8±0.2;
(2)取100g待测样品粉末,溶解或悬浮于1升的专用培养基中,37℃培养过夜;(2) Take 100 g of sample powder to be tested, dissolve or suspend it in 1 liter of special medium, and incubate overnight at 37°C;
(3)取上述得到的待测样品培养物2mL,加入50mL脑心浸液中,37℃在摇床上每分钟200转,振荡培养3小时。(3) Take 2 mL of the sample culture to be tested obtained above, add it to 50 mL of brain heart infusion, shake and cultivate for 3 hours on a shaker at 200 rpm at 37°C.
与现有技术相比,本发明的有益效果是:基于荧光PCR的鉴定方法适用于直接从患者含菌体液、食品和体液培养物等临床样品中扩增靶基因,从而检测坂崎肠杆菌。荧光PCR方法具有检测准确、特异性强、灵敏度高的特点,可以快速、准确地鉴定特异的目标细菌。它用PCR的方法扩增细菌靶基因,避免了反复培养,节约时间;PCR鉴定方法不受培养条件和细菌生理状态的影响,较生理生化鉴定方法更为准确。荧光PCR技术和普通PCR技术相比,不需电泳观察,所以具有灵敏度更高、检测速度更快且可进行定量分析的特点。本发明填补了通过荧光PCR方法检测坂崎肠杆菌的空白。Compared with the prior art, the beneficial effect of the present invention is that the identification method based on fluorescent PCR is suitable for directly amplifying target genes from clinical samples such as patient's bacteria-containing body fluid, food and body fluid culture, so as to detect Enterobacter sakazakii. The fluorescent PCR method has the characteristics of accurate detection, strong specificity and high sensitivity, and can quickly and accurately identify specific target bacteria. It uses PCR to amplify bacterial target genes, avoiding repeated cultivation and saving time; the PCR identification method is not affected by the culture conditions and the physiological state of bacteria, and is more accurate than the physiological and biochemical identification method. Compared with ordinary PCR technology, fluorescent PCR technology does not require electrophoresis observation, so it has the characteristics of higher sensitivity, faster detection speed and quantitative analysis. The invention fills up the blank of detecting Enterobacter sakazakii by the fluorescent PCR method.
附图说明Description of drawings
图1:某奶粉样品外切酶探针荧光PCR检测结果(FAM荧光信号强度)Figure 1: Exonuclease probe fluorescence PCR detection results of a milk powder sample (FAM fluorescence signal intensity)
图2:某奶粉样品外切酶探针荧光PCR报告质粒检测结果(FAM荧光信号强度)Figure 2: Detection results of a milk powder sample exonuclease probe fluorescent PCR reporter plasmid (FAM fluorescence signal intensity)
图3:某奶粉样品外切酶探针荧光PCR报告质粒检测结果(HEX荧光信号强度)Figure 3: Detection results of a milk powder sample exonuclease probe fluorescent PCR reporter plasmid (HEX fluorescence signal intensity)
图4:某奶粉样品荧光染料嵌合荧光PCR检测结果(荧光信号强度)Figure 4: Fluorescent dye chimeric fluorescent PCR detection results (fluorescent signal intensity) of a milk powder sample
图5:某奶粉样品荧光染料嵌合荧光PCR待测样品DNA扩增产物的熔解温度峰值Figure 5: The peak melting temperature of the DNA amplification product of a fluorescent dye chimeric fluorescent PCR test sample for a milk powder sample
图6:某奶粉样品中荧光染料嵌合荧光PCR报告质粒的荧光信号强度Figure 6: Fluorescent signal intensity of fluorescent dye chimeric fluorescent PCR reporter plasmid in a milk powder sample
图7:某奶粉样品中荧光染料嵌合荧光PCR报告质粒扩增产物的熔解温度峰值Figure 7: The peak melting temperature of the amplified product of fluorescent dye chimeric fluorescent PCR reporter plasmid in a milk powder sample
图8:非坂崎肠杆菌DNA在外切酶探针荧光PCR中的FAM荧光信号强度Figure 8: FAM fluorescence signal intensity of non-Enterobacter sakazakii DNA in exonuclease probe fluorescent PCR
图9:非坂崎肠杆菌DNA在外切酶探针荧光PCR中的HEX荧光信号强度Figure 9: HEX fluorescence signal intensity of non-Enterobacter sakazakii DNA in exonuclease probe fluorescent PCR
图10:非坂崎肠杆菌DNA在荧光染料嵌合PCR中的荧光信号强度Figure 10: Fluorescent signal intensity of non-Enterobacter sakazakii DNA in fluorescent dye chimeric PCR
图11:非坂崎肠杆菌DNA在荧光染料嵌合PCR中扩增报告质粒扩增片段的熔解温度Figure 11: Melting temperature of non-Enterobacter sakazakii DNA amplified by reporter plasmid in fluorescent dye chimeric PCR
具体实施方式Detailed ways
下面结合附图与具体实施方式对本发明作进一步详细描述。The present invention will be further described in detail below in conjunction with the accompanying drawings and specific embodiments.
实施例1Example 1
样本:某进口品牌婴儿配方奶粉。用常规生理、生化方法检测出坂崎肠杆菌疑似菌落,然后通过荧光信号外切酶探针PCR检测坂崎肠杆菌:Sample: An imported brand of infant formula milk powder. The suspected colony of Enterobacter sakazakii was detected by conventional physiological and biochemical methods, and then Enterobacter sakazakii was detected by fluorescent signal exonuclease probe PCR:
1.样品培养1. Sample Culture
(1)配置专用培养基:胰蛋白胨20g,乳糖5g,K2HPO4 2.75g,KH2PO4 2.75g,NaCl 34.22g,月桂基硫酸钠0.1g,万古霉素10mg,加入无菌水至1升,调pH值至6.8±0.2;(1) Configure special medium: tryptone 20g, lactose 5g, K 2 HPO 4 2.75g, KH 2 PO 4 2.75g, NaCl 34.22g, sodium lauryl sulfate 0.1g, vancomycin 10mg, add sterile water to 1 liter, adjust the pH value to 6.8±0.2;
(2)取100g奶粉溶解于1升的专用培养基中,37℃培养过夜;(2) Take 100g of milk powder and dissolve it in 1 liter of special culture medium, and cultivate overnight at 37°C;
(3)取上述得到的待测样品培养物2mL,加入50mL脑心浸液中,37℃,200转/分钟,摇床振荡培养3小时。(3) Take 2 mL of the sample culture to be tested obtained above, add it to 50 mL of brain heart infusion, and incubate on a shaker at 37° C. at 200 rpm for 3 hours.
2.DNA抽提2. DNA extraction
取脑心浸液增菌液1mL,冰浴中静置5分钟,然后在室温下12000转/分钟,离心5分钟,弃上清液,加入100μL溶菌酶溶液,37℃保温10分钟,补加TE缓冲液500μL,振荡混匀。加同体积Tris饱和酚(pH8.0),强烈振荡,12000转/分钟,离心3分钟,取上清液,重复酚抽提。取上清液,加入0.1倍体积的乙酸钠(2mol/L),混匀,再加等体积的冰乙醇,混匀后低温静置30分钟,12000转/分钟,离心5分钟,弃上清,加70%冷乙醇洗涤一次,室温下12000转/分钟,离心5分钟,弃上清,加入50μL TE溶液,置-20℃保存。Take 1 mL of brain heart infusion enrichment solution, let it stand in an ice bath for 5 minutes, then centrifuge at 12,000 rpm for 5 minutes at room temperature, discard the supernatant, add 100 μL lysozyme solution, keep warm at 37°C for 10 minutes, add TE buffer 500μL, shake and mix. Add the same volume of Tris-saturated phenol (pH 8.0), shake vigorously, centrifuge at 12,000 rpm for 3 minutes, take the supernatant, and repeat the phenol extraction. Take the supernatant, add 0.1 times the volume of sodium acetate (2mol/L), mix well, add an equal volume of ice ethanol, mix well, let stand at low temperature for 30 minutes, centrifuge at 12000 rpm for 5 minutes, discard the supernatant , washed once with 70% cold ethanol, centrifuged at 12,000 rpm for 5 minutes at room temperature, discarded the supernatant, added 50 μL TE solution, and stored at -20°C.
3.PCR扩增3.PCR amplification
PCR反应体系:PCR reaction system:
成分 浓度 加样量Composition Concentration Sample Amount
PCR体系预混合物 2倍 12.5μLPCR system premix 2 times 12.5μL
探针法所用引物序列1 10μmol/L 0.5μLPrimer sequence used in
探针法所用引物序列2 10μmol/L 0.5μLPrimer sequence used in
探针法所用探针序列1 3μmol/L 1μLProbe sequence used in
探针法所用探针序列2 3μmol/L 1μLProbe sequence used in
DNA样品 1μLDNA sample 1μL
报告质粒 103个/μL 1μL
双蒸水 7.5μLDouble distilled water 7.5μL
总体积 25μLTotal volume 25μL
PCR扩增程序:PCR amplification program:
(1)95℃ 10秒(1) 95°C for 10 seconds
(2)95℃ 5秒(2) 95°C for 5 seconds
(3)62℃ 20秒(3) 62°C for 20 seconds
(4)回到第(2)步,重复45次。(4) Go back to step (2) and repeat 45 times.
共进行7管PCR实验,其中DNA样品分别为:坂崎肠杆菌标准菌株ATCC12868 阳性对照;原浓度DNA样品;10倍稀释DNA样品;102倍稀释DNA样品;103倍稀释DNA样品;104倍稀释DNA样品;仅有报告质粒无样品的阴性对照。A total of 7 tubes of PCR experiments were carried out, in which the DNA samples were: Enterobacter sakazakii standard strain ATCC12868 positive control; original concentration DNA sample; 10-fold diluted DNA sample; 10 2 -fold diluted DNA sample; 10 3 -fold diluted DNA sample; 10 4 -fold Diluted DNA sample; negative control with no sample for reporter plasmid only.
4.被检测样品荧光PCR图谱观察4. Observation of the fluorescence PCR pattern of the tested sample
荧光PCR过程中可以观察到标准菌株阳性对照及各浓度样品分别在18.36;22.25;25.83;29.75;33.5;36.5循环产生了明显的FAM荧光,结果见图1。During the fluorescent PCR process, it can be observed that the positive control of the standard strain and the samples of various concentrations produced obvious FAM fluorescence at cycles of 18.36; 22.25; 25.83; 29.75; 33.5;
图1:某奶粉样品外切酶探针荧光PCR检测结果(FAM荧光信号强度)Figure 1: Exonuclease probe fluorescence PCR detection results of a milk powder sample (FAM fluorescence signal intensity)
图中的各条曲线所代表的FAM荧光强度信号分别是:The FAM fluorescence intensity signals represented by each curve in the figure are:
1.坂崎肠杆菌标准菌株ATCC12868;1. Enterobacter sakazakii standard strain ATCC12868;
2.原浓度DNA样品;2. Original concentration DNA sample;
3.10倍稀释DNA样品;3. 10 times diluted DNA sample;
4.102倍稀释DNA样品;4.10 2 -fold diluted DNA sample;
5.103倍稀释DNA样品;5.10 3 times diluted DNA sample;
6.104倍稀释DNA样品;6.10 4 times diluted DNA samples;
阴性对照中在PCR过程中没有产生FAM荧光,结果见图2。In the negative control, no FAM fluorescence was generated during the PCR process, and the results are shown in Figure 2.
图2:某奶粉样品外切酶探针荧光PCR报告质粒检测结果(FAM荧光信号强度)Figure 2: Detection results of a milk powder sample exonuclease probe fluorescent PCR reporter plasmid (FAM fluorescence signal intensity)
图中的曲线所代表的FAM荧光强度信号是:The FAM fluorescence intensity signal represented by the curve in the figure is:
1.仅有报告质粒无样品的阴性对照。1. Negative control with only reporter plasmid and no sample.
但在34.19循环产生了报告质粒的HEX荧光,结果见图3。However, the HEX fluorescence of the reporter plasmid was generated at cycle 34.19, and the results are shown in Figure 3.
图3:某奶粉样品外切酶探针荧光PCR报告质粒检测结果(HEX荧光信号强度)Figure 3: Detection results of a milk powder sample exonuclease probe fluorescent PCR reporter plasmid (HEX fluorescence signal intensity)
图中的曲线所代表的HEX荧光强度信号是:The HEX fluorescence intensity signal represented by the curve in the figure is:
1.仅有报告质粒无样品的阴性对照。1. Negative control with only reporter plasmid and no sample.
以上实验表明,样品中含有坂崎肠杆菌。The above experiments showed that the samples contained Enterobacter sakazakii.
2天后,通过常规微生物培养和生化检测证明,所检验的目的菌落98%为坂崎肠杆菌,其中一个菌株命名为gq103。荧光信号外切酶探针PCR检验结果与生化检测结果一致。After 2 days, routine microbial culture and biochemical testing proved that 98% of the tested target colonies were Enterobacter sakazakii, and one of the strains was named gq103. The fluorescent signal exonuclease probe PCR test results were consistent with the biochemical test results.
实施例2Example 2
样本:某国产品牌婴儿配方奶粉。用常规生理、生化方法检测出坂崎肠杆菌疑似菌落,然后通过荧光信号荧光染料嵌合途径检测坂崎肠杆菌:Sample: A domestic brand of infant formula milk powder. The suspected colony of Enterobacter sakazakii was detected by conventional physiological and biochemical methods, and then Enterobacter sakazakii was detected by the chimera pathway of fluorescent signal fluorescent dye:
1.样品培养:1. Sample culture:
同实施例1。With
2.DNA抽提2. DNA extraction
同实施例1。With
3.PCR扩增3.PCR amplification
PCR反应体系中各组分构成比例如下:The composition ratio of each component in the PCR reaction system is as follows:
成分 浓度 加样量Composition Concentration Concentration Sample Amount
PCR体系预混合物 2倍 12.5μLPCR system premix 2 times 12.5μL
荧光嵌合法所用引物序列1: 10μmol/L 0.5μL
荧光嵌合法所用引物序列2: 10μmol/L 0.5μL
DNA样品 1μLDNA sample 1μL
报告质粒 103个/μL 1μL
双蒸水 9.5μLDouble distilled water 9.5μL
总体积 25μLTotal volume 25μL
PCR方法中扩增程序及测定扩增片段的熔解温度程序为:In the PCR method, the amplification program and the melting temperature program for determining the amplified fragment are:
(1)95℃ 10秒(1) 95°C for 10 seconds
(2)95℃ 5秒(2) 95°C for 5 seconds
(3)58℃至65℃间的某一温度20秒(3) A certain temperature between 58°C and 65°C for 20 seconds
(4)回到第(2)步,重复45次。(4) Go back to step (2) and repeat 45 times.
(5)95℃ 2分(5) 95℃ for 2 minutes
(6)梯度升温55℃至95℃,每25秒上升1℃。(6) Gradient temperature increase from 55°C to 95°C, increasing by 1°C every 25 seconds.
共进行7管PCR实验,其中DNA样品分别为:坂崎肠杆菌标准菌株ATCC29004阳性对照;原浓度DNA样品;10倍稀释DNA样品;102倍稀释DNA样品;103倍稀释DNA样品;104倍稀释DNA样品;仅有报告质粒无样品的阴性对照。A total of 7 tubes of PCR experiments were carried out, in which the DNA samples were: Enterobacter sakazakii standard strain ATCC29004 positive control; original concentration DNA sample; 10-fold diluted DNA sample; 10 2 -fold diluted DNA sample; 10 3 -fold diluted DNA sample; 10 4 -fold Diluted DNA sample; negative control with no sample for reporter plasmid only.
4.被检测样品荧光PCR图谱观察及熔解曲线观察4. Observation of fluorescence PCR spectrum and melting curve of the tested sample
荧光PCR过程中可以观察到标准菌株阳性对照及各浓度样品产生了明显的荧光,见图4。During the fluorescent PCR process, it can be observed that the positive control of the standard strain and samples of various concentrations produced obvious fluorescence, as shown in Figure 4.
图4:某奶粉样品荧光染料嵌合荧光PCR检测结果(荧光信号强度)Figure 4: Fluorescent dye chimeric fluorescent PCR detection results (fluorescent signal intensity) of a milk powder sample
图中的各条曲线所代表的荧光强度信号分别是:The fluorescence intensity signals represented by each curve in the figure are:
1.坂崎肠杆菌标准菌株ATCC29004;1. Enterobacter sakazakii standard strain ATCC29004;
2.原浓度DNA样品;2. Original concentration DNA sample;
3.10倍稀释DNA样品;3. 10 times diluted DNA sample;
4.102倍稀释DNA样品;4.10 2 -fold diluted DNA sample;
5.103倍稀释DNA样品;5.10 3 times diluted DNA sample;
6.104倍稀释DNA样品;6.10 4 times diluted DNA samples;
其熔解温度符合坂崎肠杆菌的特性,见图5。Its melting temperature conforms to the characteristics of Enterobacter sakazakii, as shown in Figure 5.
图5:某奶粉样品荧光染料嵌合荧光PCR待测样品DNA扩增产物的熔解温度峰值Figure 5: The peak melting temperature of the DNA amplification product of a fluorescent dye chimeric fluorescent PCR test sample for a milk powder sample
图中的多条曲线的峰值重合,所代表的意义分别是:The peak coincidence of multiple curves in the figure means:
1.报告质粒扩增片段的熔解温度1. Report the melting temperature of the amplified fragment of the plasmid
2.坂崎肠杆菌熔解温度次峰2. Sub-peak of melting temperature of Enterobacter sakazakii
3.坂崎肠杆菌熔解温度主峰3. Main peak of melting temperature of Enterobacter sakazakii
阴性对照中报告质粒在PCR过程也产生了荧光结果,见图6。The reporter plasmid in the negative control also produced fluorescent results during the PCR process, as shown in Figure 6.
图6:某奶粉样品中荧光染料嵌合荧光PCR报告质粒的荧光信号强度Figure 6: Fluorescent signal intensity of fluorescent dye chimeric fluorescent PCR reporter plasmid in a milk powder sample
图中的曲线所代表的荧光强度信号是:The fluorescence intensity signal represented by the curve in the figure is:
1.仅有报告质粒无样品的阴性对照。1. Negative control with only reporter plasmid and no sample.
其熔解温度符合质粒特性,见图7。Its melting temperature conforms to the characteristics of the plasmid, as shown in Figure 7.
图7:某奶粉样品中荧光染料嵌合荧光PCR报告质粒扩增产物的熔解温度峰值Figure 7: The peak melting temperature of the amplified product of fluorescent dye chimeric fluorescent PCR reporter plasmid in a milk powder sample
图中的曲线所代表的熔解温度是:The melting temperature represented by the curve in the figure is:
1.报告质粒扩增片段的熔解温度1. Report the melting temperature of the amplified fragment of the plasmid
上述实验表明,样品中含有坂崎肠杆菌。The above experiments showed that the samples contained Enterobacter sakazakii.
2天后,通过常规微生物培养和生化检测证明,所检验的目的菌落98%为坂崎肠杆菌,其中一个菌株命名为gq105。荧光染料嵌合PCR检验结果与生化检测结果一致。After 2 days, routine microbial culture and biochemical testing proved that 98% of the tested target colonies were Enterobacter sakazakii, and one of the strains was named gq105. Fluorescent dye chimeric PCR test results were consistent with biochemical test results.
实施例3Example 3
样本:对肠杆菌科中5种和坂崎肠杆菌亲缘关系较近的菌种进行培养,所用菌株为大肠杆菌、阴沟肠杆菌、产气肠杆菌、弗劳地枸橼酸杆菌和蜂房哈夫尼亚菌。Sample: 5 strains of Enterobacteriaceae that are closely related to Enterobacter sakazakii were cultured, the strains used were Escherichia coli, Enterobacter cloacae, Enterobacter aerogenes, Citrobacter freundii and Haffney hive Subbacteria.
1.DNA抽提1. DNA extraction
取增菌液1mL在冰浴中静置5分钟,然后在室温下12000转/分钟,离心5分钟,弃上清液,加入100μL溶菌酶溶液,37℃保温10分钟,补加TE缓冲液500μL,振荡混匀。加同体积Tris饱和酚(pH8.0),强烈振荡,12000转/分钟离心3分钟,取上清液,重复酚抽提。取上清液,加入0.1倍体积的乙酸钠(2mol/L),混匀,再加等体积的冰乙醇,混匀后低温静置30分钟,12000转/分钟,离心5分钟,弃上清,加70%冷乙醇洗涤一次,室温下12000转/分钟,离心5分钟,弃上清,加入50μL TE溶液,置-20℃保存。Take 1 mL of the enrichment solution and let it stand in an ice bath for 5 minutes, then centrifuge at 12,000 rpm for 5 minutes at room temperature, discard the supernatant, add 100 μL of lysozyme solution, incubate at 37°C for 10 minutes, and add 500 μL of TE buffer , shake to mix. Add the same volume of Tris-saturated phenol (pH 8.0), shake vigorously, centrifuge at 12,000 rpm for 3 minutes, take the supernatant, and repeat the phenol extraction. Take the supernatant, add 0.1 times the volume of sodium acetate (2mol/L), mix well, add an equal volume of ice ethanol, mix well, let stand at low temperature for 30 minutes, centrifuge at 12000 rpm for 5 minutes, discard the supernatant , washed once with 70% cold ethanol, centrifuged at 12,000 rpm for 5 minutes at room temperature, discarded the supernatant, added 50 μL TE solution, and stored at -20°C.
2.荧光PCR扩增分别通过两种途径报告荧光信号2. Fluorescent PCR amplification reports fluorescent signals through two ways
(1)通过外切酶探针途径报告荧光信号,其PCR反应体系中各组分构成比例如下:(1) The fluorescent signal is reported through the exonuclease probe approach, and the composition ratio of each component in the PCR reaction system is as follows:
成分 浓度 加样量Composition Concentration Concentration Sample Amount
PCR体系预混合物 2倍 12.5μLPCR system premix 2 times 12.5μL
探针法所用引物序列1 10μmol/L 0.5μLPrimer sequence used in
探针法所用引物序列2 10μmol/L 0.5μLPrimer sequence used in
探针法所用探针序列1 3μmol/L 1μLProbe sequence used in
探针法所用探针序列2 3μmol/L 1μLProbe sequence used in
DNA样品 1μLDNA sample 1μL
报告质粒 103个/μL 1μL
双蒸水 7.5μLDouble distilled water 7.5μL
总体积 25μLTotal volume 25μL
PCR扩增程序:PCR amplification program:
(1)95℃ 10秒(1) 95°C for 10 seconds
(2)95℃ 5秒(2) 95°C for 5 seconds
(3)62℃ 20秒(3) 62°C for 20 seconds
(4)回到第(2)步,重复45次。(4) Go back to step (2) and repeat 45 times.
共进行5管PCR实验,其中DNA样品分别为:大肠杆菌、阴沟肠杆菌、产气肠杆菌、弗劳地枸橼酸杆菌和蜂房哈夫尼亚菌。对被检测样品进行的荧光PCR图谱表明,没有产生FAM荧光,结果见图8。A total of 5 tubes of PCR experiments were carried out, in which the DNA samples were: Escherichia coli, Enterobacter cloacae, Enterobacter aerogenes, Citrobacter freundii and Hafnia alveoli. The fluorescence PCR spectrum of the tested sample showed that no FAM fluorescence was produced, and the results are shown in FIG. 8 .
图8:非坂崎肠杆菌DNA在外切酶探针荧光PCR中的FAM荧光信号强度Figure 8: FAM fluorescence signal intensity of non-Enterobacter sakazakii DNA in exonuclease probe fluorescent PCR
图中的曲线所代表的FAM荧光强度信号是:五条重合在一起的荧光信号为0的曲线。但均在35循环附近产生了报告质粒的HEX荧光,结果见图9。The FAM fluorescence intensity signals represented by the curves in the figure are: five superimposed curves whose fluorescence signal is 0. However, the HEX fluorescence of the reporter plasmid was generated around 35 cycles, and the results are shown in Figure 9.
图9:非坂崎肠杆菌DNA在外切酶探针荧光PCR中的HEX荧光信号强度Figure 9: HEX fluorescence signal intensity of non-Enterobacter sakazakii DNA in exonuclease probe fluorescent PCR
图中的曲线所代表的HEX荧光强度信号是:五条近似重合的报告质粒所产生的HEX荧光强度信号,证明所测样品中没有坂崎肠杆菌。实验表明,通过外切酶探针荧光PCR检测,不会对这五种细菌产生坂崎肠杆菌阳性信号。The HEX fluorescence intensity signal represented by the curve in the figure is: the HEX fluorescence intensity signal produced by five nearly overlapping reporter plasmids, which proves that there is no Enterobacter sakazakii in the tested sample. Experiments have shown that the detection of exonuclease probe fluorescent PCR will not produce positive signals for Enterobacter sakazakii for these five bacteria.
(2)通过荧光染料嵌合PCR反应报告荧光信号,PCR反应体系如下:(2) Fluorescent signal is reported by fluorescent dye chimeric PCR reaction, and the PCR reaction system is as follows:
成分 浓度 加样量Composition Concentration Sample Amount
PCR体系预混合物 2倍 12.5μLPCR system premix 2 times 12.5μL
荧光嵌合法所用引物序列1 10μmol/L 0.5μLPrimer sequence for fluorescent
荧光嵌合法所用引物序列2 10μmol/L 0.5μLPrimer sequence for fluorescent
DNA样品 1μLDNA sample 1μL
报告质粒 103个/μL 1μL
双蒸水 9.5μLDouble distilled water 9.5μL
总体积 25μLTotal volume 25μL
PCR方法中扩增程序及测定扩增片段的熔解温度程序:Amplification procedure and the melting temperature procedure of measuring amplified fragment in the PCR method:
(1)95℃ 10秒(1) 95°C for 10 seconds
(2)95℃ 5秒(2) 95°C for 5 seconds
(3)62℃ 20秒(3) 62°C for 20 seconds
(4)回到第(2)步,重复45次。(4) Go back to step (2) and repeat 45 times.
(5)95℃ 2分(5) 95℃ for 2 minutes
(6)梯度升温55℃至95℃,每25秒上升1℃。(6) Gradient temperature increase from 55°C to 95°C, increasing by 1°C every 25 seconds.
共进行6管PCR实验,其中DNA样品分别为大肠杆菌;大肠杆菌O157H7;阴沟肠杆菌;产气肠杆菌;弗劳地枸橼酸杆菌;蜂房哈夫尼亚菌。对被检测样品进行荧光PCR图谱观察及熔解曲线观察,结果表明,荧光PCR过程中可以观察到各阴性菌中报告质粒在PCR过程中产生HEX荧光,结果见图10。A total of 6 PCR experiments were carried out, in which the DNA samples were Escherichia coli; Escherichia coli O157H7; Enterobacter cloacae; Enterobacter aerogenes; Citrobacter freundii; Hafnia hives. Observation of fluorescent PCR patterns and melting curves of the tested samples showed that during the fluorescent PCR process, the reporter plasmids in each negative bacteria could be observed to produce HEX fluorescence during the PCR process. The results are shown in Figure 10.
图10:非坂崎肠杆菌DNA在荧光染料嵌合PCR中的荧光信号强度Figure 10: Fluorescent signal intensity of non-Enterobacter sakazakii DNA in fluorescent dye chimeric PCR
图中的曲线所代表的荧光强度信号是:各阴性菌实验中报告质粒所产生的荧光信号重合曲线。但熔解温度符合质粒特性,见图11。The fluorescence intensity signal represented by the curve in the figure is: the superposition curve of the fluorescence signal produced by the reporter plasmid in each negative bacteria experiment. But the melting temperature conforms to the characteristics of the plasmid, as shown in Figure 11.
图11:非坂崎肠杆菌DNA在荧光染料嵌合PCR中扩增报告质粒扩增片段的熔解温度Figure 11: Melting temperature of non-Enterobacter sakazakii DNA amplified by reporter plasmid in fluorescent dye chimeric PCR
图中曲线所代表的是报告质粒扩增片段的熔解温度。实验表明,通过荧光染料嵌合PCR检测,不会对这五种细菌产生坂崎肠杆菌阳性信号。The curve in the figure represents the melting temperature of the amplified fragment of the reporter plasmid. Experiments showed that the positive signals of Enterobacter sakazakii would not be generated for these five bacteria by fluorescent dye chimeric PCR detection.
序列列表sequence list
SEQUENCE LISTINGSEQUENCE LISTING
<110>中华人民共和国天津出入境检验检疫局<110> Tianjin Entry-Exit Inspection and Quarantine Bureau of the People's Republic of China
<120>运用荧光PCR技术检测坂崎肠杆菌的方法<120> Method for detecting Enterobacter sakazakii using fluorescent PCR technology
<130>041122<130>041122
<160>8<160>8
<170>PatenyIn version 3.1<170> PatenyIn version 3.1
<210>1<210>1
<211>21<211>21
<212>DNA<212>DNA
<213>人工合成<213> Synthetic
<220><220>
<221>primer_bind<221>primer_bind
<222>(1)..(21)<222>(1)..(21)
<223><223>
<400>1<400>1
ccggaacaag ctgaaaattc t 21ccggaacaag ctgaaaattc t 21
<210>2<210>2
<211>19<211>19
<212>DNA<212>DNA
<213>人工合成<213> Synthetic
<220><220>
<221>primer_bind<221>primer_bind
<222>(1)..(19)<222>(1)..(19)
<223><223>
<400>2<400>2
gtcttcgtgc tgcgattac 19gtcttcgtgc tgcgattac 19
<210>3<210>3
<211>22<211>22
<212>DNA<212>DNA
<213>人工合成<213> Synthetic
<220><220>
<221>misc_structure<221>misc_structure
<222>(1)..(22)<222>(1)..(22)
<223><223>
<400>3<400>3
actctgacac cgcgcattcc tg 22actctgacac cgcgcattcc tg 22
<210>4<210>4
<211>24<211>24
<212>DNA<212>DNA
<213>人工合成<213> Synthetic
<220><220>
<221>misc_structure<221>misc_structure
<222>(1)..(24)<222>(1)..(24)
<223><223>
<400>4<400>4
cctttggcgt ttcccgatgt ccgt 24cctttggcgt ttcccgatgt ccgt 24
<210>5<210>5
<211>82<211>82
<212>DNA<212>DNA
<213>人工合成<213> Synthetic
<220><220>
<221>misc_difference<221>misc_difference
<222>(1)..(82)<222>(1)..(82)
<223><223>
<400>5<400>5
ggagggattg cagcgtgttt ttaatgaggt catcacggga tcccatgtgc gtgacggaca 60ggagggattg cagcgtgttt ttaatgaggt catcacggga tcccatgtgc gtgacggaca 60
tcgggaaacg ccaaaggaga tt 82tcgggaaacg ccaaaggaga tt 82
<210>6<210>6
<211>20<211>20
<212>DNA<212>DNA
<213>人工合成<213> Synthetic
<220><220>
<221>misc_difference<221>misc_difference
<222>(1)..(20)<222>(1)..(20)
<223><223>
<400>6<400>6
gggttgtctg cgaatcgctt 20
<210>7<210>7
<211>20<211>20
<212>DNA<212>DNA
<213>人工合成<213> Synthetic
<220><220>
<221>misc_difference<221>misc_difference
<222>(1)..(20)<222>(1)..(20)
<223><223>
<400>7<400>7
gggttgtctg cgaatcgctt 20
<210>8<210>8
<211>60<211>60
<212>DNA<212>DNA
<213>人工合成<213> Synthetic
<220><220>
<221>misc_structure<221>misc_structure
<222>(1)..(60)<222>(1)..(60)
<223><223>
<400>8<400>8
tccgttcttc ttcggtcataa cttaatgttt ttatttaaaa taccctctga aaagaaagga 60tccgttcttc ttcggtcataa cttaatgttt ttattaaaa taccctctga aaagaaagga 60
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2004100728528A CN1281763C (en) | 2004-11-22 | 2004-11-22 | Process for detecting Enterobacter sakazakii by employing fluorescence PCR technology |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2004100728528A CN1281763C (en) | 2004-11-22 | 2004-11-22 | Process for detecting Enterobacter sakazakii by employing fluorescence PCR technology |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1635156A CN1635156A (en) | 2005-07-06 |
CN1281763C true CN1281763C (en) | 2006-10-25 |
Family
ID=34846793
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2004100728528A Expired - Fee Related CN1281763C (en) | 2004-11-22 | 2004-11-22 | Process for detecting Enterobacter sakazakii by employing fluorescence PCR technology |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1281763C (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101419169B (en) * | 2008-01-11 | 2010-11-10 | 华南农业大学 | Method for identifying bentgrass nematode by real time fluorescent PCR technology |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101368204B (en) * | 2008-09-16 | 2011-08-31 | 中国计量学院 | Fast detection primer and reagent kit for enterobacter sakazakii hymenial veil mediated isothermality amplification technique |
CN103484557A (en) * | 2013-10-15 | 2014-01-01 | 上海市计量测试技术研究院 | Plasmid standard molecule applicable to real-time fluorescence quantification PCR (Polymerase Chain Reaction) detection of enterobacter sakazakii |
-
2004
- 2004-11-22 CN CNB2004100728528A patent/CN1281763C/en not_active Expired - Fee Related
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101419169B (en) * | 2008-01-11 | 2010-11-10 | 华南农业大学 | Method for identifying bentgrass nematode by real time fluorescent PCR technology |
Also Published As
Publication number | Publication date |
---|---|
CN1635156A (en) | 2005-07-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1711357A (en) | One step real-time RT PCR kits for the universal detection of organisms in industrial products | |
CN1840693A (en) | Gram-negative bacterial drug resistance gene detection method and its special chip and kit | |
CN1252261C (en) | Design and construction of transcription template for synthesizing cell-free protein, and dilution batch-type method of synthesizing cell-free wheat germ protein | |
CN1304599C (en) | Medicine and bacterium resistant detection chip, method for preparation and application thereof | |
CN1281763C (en) | Process for detecting Enterobacter sakazakii by employing fluorescence PCR technology | |
CN1202244C (en) | Novel protein having aspartase activity and gene DNA coding for the same | |
CN1813064A (en) | Method of detecting SARS coronavirus | |
CN1720335A (en) | Multiple analytical detection of pathogenic organisms | |
CN100340675C (en) | Transgene tobacco detecting method and reagent box | |
CN1274850C (en) | Turbot reddish body iridovirus virus polymerase chain reaction detection method | |
CN1174104C (en) | Artificial sequence template primer collection and its use | |
CN1670220A (en) | Primer and probe series for real time fluorescent RT-PCR detection of bird flu of H7 subtype | |
CN1247796C (en) | Quantitative measuring transgene component in transgene rapeseed and processed product | |
CN1814787A (en) | Ramie micro-satellite DNA Label | |
CN1828299A (en) | Nucleotide sequence, kit and test method for detecting avian influenza virus | |
CN101074449A (en) | Gene chip for analyzing microbial group structure and function under acid environment | |
CN1514022A (en) | Detection of main pathogenic microorganism in medicine | |
CN1664112A (en) | Method for detecting Enterobacter sakazakii by polymerase chain reaction technique | |
CN1969048A (en) | Method for study of the genetic and functional variability of HIV and kit for using it | |
CN1772903A (en) | Novel fructan sucrase gene and its application | |
CN1206356C (en) | Breeding of hepatitis A virus Chinese strain and attenuated strain and its complementary DNA sequence | |
CN1680593A (en) | Norovirus Detection Reagent | |
CN1176214C (en) | A method for promoting freezing and killing insects | |
CN1271213C (en) | Chip for detecting meningitis, its preparation method and application | |
CN1904071A (en) | A kind of method for distinguishing the pros and cons of production traits of spirulina strains |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20061025 |